Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 30 min ago
Peer-reviewedCC BY-NC-NDThe journal of pathology. Clinical research

The molecular pathological basis and potential clinical applications of ‘zero‐budding’ status in stage II colorectal cancer

  • Ying‐nan Liu1
  • Ben Wang1
  • Qian Xu1
  1. 1The First Hospital of China Medical University
Read full textPDFCite

Related

  1. Clinical, Pathological, and Molecular Characteristics in Colorectal Cancer
    Stéphane Dedieu, Olivier Bouché
    CancersPeer-reviewedCC BY 4.0Full text4 citedGeneral biologyOncologyHAL
  2. Molecular and microenvironmental networks driving tumor dormancy: pathological mechanisms and emerging clinical strategies
    Yuanshuai Li, Wenling Zhan, Min Min +4
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Toward Precision Colorectal Cancer Screening: Integrating Clinical Risk Stratification, Molecular Biomarkers, and Artificial Intelligence
    Sorinel Lunca, Stefan Morarasu, Gabriel Mihail Dimofte
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. The Molecular, Genetic, Pathological Basis and Clinical Perspectives of Endometrial Cancer: A Narrative Review
    Chia-Ling Chang, Jie-Hong Chen, Kuo-Hu Chen
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Obstetrics, gynaecology & paediatricsCrossref
  5. Circulating Tumor DNA (ctDNA) for Minimal Residual Disease (MRD) Detection in Colorectal Cancer (CRC): Current Evidence, Clinical Applications, and Future Directions.
    Hannah Hyde, Emma Mageau, Chelsea M Leduc +8
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textOncologyEurope PMC

Cite

BibTeXRIS
BibTeX
@article{liu2026molecular,
  title = {{The molecular pathological basis and potential clinical applications of ‘zero‐budding’ status in stage II colorectal cancer}},
  author = {Ying‐nan Liu and Ben Wang and Qian Xu},
  journal = {The journal of pathology. Clinical research},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13691417},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - The molecular pathological basis and potential clinical applications of ‘zero‐budding’ status in stage II colorectal cancer
AU  - Ying‐nan Liu
AU  - Ben Wang
AU  - Qian Xu
PY  - 2026
DA  - 2026/10/22
JO  - The journal of pathology. Clinical research
UR  - https://europepmc.org/article/PMC/PMC13691417
SN  - 2056-4538
ER  -